Evidence map›Paper›PMID 38482405›Full record

ArticleTranslational cancer research2024

Multivariate logistic regression analysis of the clinical factors influencing locally advanced prostate cancer.

Zongpan Ke, Yan Xu, Yawei Shu, Changming Wang, Baorui Wu, Bin Zhang, Ping Xiang, Xuechun Hu

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zongpan Ke *Department of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yan Xu *Department of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yawei ShuDepartment of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Changming WangDepartment of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Baorui WuDepartment of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Bin ZhangDepartment of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Ping XiangDepartment of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Xuechun HuDepartment of Urology, The First Affiliated Hospital of USTC (the University of Science and Technology of China), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
University of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Locally advanced prostate cancer (PCa) carries a high risk of recurrence and metastasis after surgery, and the prognosis is poor. We explored the risk factors for locally advanced PCa among clinical factors (neutrophil: lymphocyte ratio, lymphocyte: monocyte ratio) and indicators of systemic inflammation [prostate-specific antigen (PSA) level, Gleason score, body mass index (BMI)] through retrospective evaluation of patients with PCa diagnosed at our center. The pathologic T stage was a key indicator of locally advanced PCa. Methods: Data from patients with pathologically confirmed PCa at our center from 1 January 2015 to 1 May 2020 were collected in strict accordance with inclusion and exclusion criteria. Clinical data were collected and the relationship between the indicators and the pathologic T stage was explored. First, Spearman rank correlation analysis was used to find the correlates of the pathologic T stage. Then, logistic ordered multiple regression analysis was used to identify independent risk factors. Finally, receiver operating characteristic (ROC) curves were used to assess the diagnostic accuracy for the T stage of PCa. Results: After rigorous screening, the data of 177 patients were obtained. Spearman correlation analysis showed that BMI, the PSA level, Gleason score, hypertension, N stage, and M stage were significantly correlated with the T stage (P<0.05), suggesting that these factors may be involved in locally advanced PCa. Analyses of ROC curves showed that the PSA level [area under the ROC curve (AUC) =0.802] had greater value than BMI (0.675) for the diagnosis of the pathologic T stage PCa, and that a combination of BMI and PSA (combined AUC =0.822) could improve locally advanced PCa diagnosis. Conclusions: BMI and PSA are independent risk factors for locally advanced PCa. They may play a key part in locally advanced PCa.

Indexed as

body mass index (BMI)Locally advanced prostate cancerprostate-specific antigen (PSA)T stage

Identifiers

PMID38482405
PMCPMC10928594
OpenAlexW4392301073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.